葡萄糖生物标志物和抗抑郁药反应:针对重度抑郁症和代谢功能障碍的干预措施的范围审查
Dara Silver1, Maria Vasileiadi2, Maggie S Stewart2
1Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada; Harquail Centre for Neuromodulation, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
Journal of affective disorders
|November 14, 2025
概括
葡萄糖失调与严重抑郁症 (MDD) 有关. 像HbA1c这样的葡萄糖生物标志物的改善与对各种治疗的更好的抗抑郁药反应相关,这表明代谢健康在心理健康中起着作用.
科学领域:
- 代谢精神病学 代谢精神病学
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
背景情况:
- 越来越多的证据将葡萄糖失调与严重抑郁症 (MDD) 病理生理学联系起来.
- 代谢标记与抗抑郁药治疗结果有关.
- 本综述探讨了葡萄糖生物标志物和抗抑郁药反应.
研究的目的:
- 综合审查葡萄糖生物标志物 (HbA1c,禁食葡萄糖,胰岛素) 与抗抑郁药物反应之间的关联.
- 研究针对代谢功能障碍或抑郁症状的干预措施.
- 了解葡萄糖调节在治疗疗效中的作用.
主要方法:
- 3个数据库的系统搜索和手动参考列表搜索 (78项研究,32434名参与者).
- 包括的研究评估了诸如药物,行为疗法,糖尿病治疗和神经调节等干预措施.
- 专注于随机对照试验,在开放科学框架上进行前性注册.
主要成果:
- 葡萄糖生物标志物 (特别是HbA1c) 的降低经常与抑郁症状的改善相吻合.
- 药理和行为干预显示出同时产生情绪和代谢效应.
- 特定于糖尿病的治疗对抑郁症有不同的影响;神经调节的发现是混合的.
结论:
- 强调葡萄糖调节和抗抑郁药对药物治疗,心理治疗和行为干预的反应之间的相互联系.
- 强调需要研究葡萄糖生物标志物作为治疗结果的潜在指标.
- 建议进一步调查有关神经调节治疗结果的葡萄糖生物标志物.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
784
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
784
Oral Hypoglycemic Agents: Biguanides and Glitazones
568
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
568
Hypoglycemia and Glucagon
787
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
787
Overview of Carbohydrate Metabolism
3.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.2K
Glucagon-like Receptor Agonists
828
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
828
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K


